Decline in drug overdose deaths after state policy changes — Florida, 2010-2012

Morbidity and Mortality Weekly Report

Volumn , Issue 26, 2014, Pages 569-574

  Johnson, Hal ^a   Paulozzi, Leonard ^b   Porucznik, Christina ^c   Mack, Karin ^b   Herter, Blake ^a  

^a FLORIDA DEPARTMENT OF HEALTH   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; OXYCODONE; PRESCRIPTION DRUG; STREET DRUG;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL PRACTICE; DRUG OVERDOSE; FEMALE; HEALTH CARE POLICY; HUMAN; INFANT; LAW ENFORCEMENT; LEGAL ASPECT; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; PRESCRIPTION; STATISTICS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ALPRAZOLAM; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DRUG OVERDOSE; DRUG PRESCRIPTIONS; FEMALE; FLORIDA; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; LAW ENFORCEMENT; MALE; MIDDLE AGED; OXYCODONE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; STREET DRUGS; YOUNG ADULT;

EID: 84903710836     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Drug overdose deaths—Florida, 2003-2009. MMWR 2011;60:869-72.
2. Florida Office of the Attorney General. Statewide Task Force on Prescription Drug Abuse and Newborns, 2014 progress report. Tallahassee, FL: Florida Office of the Attorney General; 2014. Available at http://www.myfloridalegal.com/webfiles.nsf/wf/jmee-9gus2x/$file/progressreportonline.pdf.
3. Santos A. Combating pharmaceutical diversion: targeting “rogue pain clinics” and “pill mills”. Presented at the 2013 Prescription Drug Awareness Conference; Detroit, MI; May 4-5, 2013. Available at http://www.deadiversion.usdoj.gov/mtgs/pharm_awareness/conf_2013/may_2013/santosII.pdf.
4. Florida Department of Law Enforcement. Drugs identified in deceased persons by Florida medical examiners, 2012 report. Tallahassee, FL: Florida Department of Law Enforcement; 2012. Available at www.fdle.state.fl.us/content/getdoc/79241c67-253b-45eb-a238-1a07cf4a2a0c/2012-drug-report_final.aspx.
5. IMS Institute for Healthcare Informatics. National Prescription Audit. Collegeville, PA: IMS Health; 2013. Available at http://www.imshealth.com/deployedfiles/ims/global/content/insights/researchers/npa_data_brief.pdf.
6. Surratt H, O’Grady C, Kurtz S, et al. Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Saf 2014;23:314-20.
7. Severtson S, Bartelson B, Davis J, et al. Difference in rates of abuse following reformulation of extended release oxycodone using data from the RADARS System Poison Center Program. Ann Emerg Med 2012;60:S34.
8. Slavova S, Bunn T, Lambert J. Drug overdose deaths, hospitalizations, and emergency department visits in Kentucky, 2000-2012. Lexington, KY: Kentucky Injury Prevention and Research Center; 2014. Available at http://www.mc.uky.edu/kiprc/pdf/drug-overdose-report.pdf.
9. Paulozzi LJ, Ibrahimova A, Rudd R, Goldberger B, Thogmartin J, Shelton K. A comparison of Florida medical examiners’ reports and death certificates for specific drug related overdose deaths. Acad Foren Path 2012;2:a-b.
10. CDC. Prevention status reports (PSRs): prescription drug overdose PSR, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://www.cdc.gov/stltpublichealth/psr/prescriptiondrug/index.html.